Íîðìàòèâíà áàçà

˳êàðñüê³ çàñîáè

²íø³ ðîçä³ëè

Çâîðîòí³é çâ'ÿçîê

Ðåàãåíòè äëÿ êë³í³÷íî¿ á³îõ³ì³¿

Íàçâà âèðîáó: Ðåàãåíòè äëÿ êë³í³÷íî¿ á³îõ³ì³¿
Ñâ³äîöòâî ïðî ðåºñòðàö³þ: ¹ 9534/2010, â³ä 01.07.2010 ð.
Íàêàç ÌÎÇ: ¹ 140, â³ä 01.07.2010 ð.
Êîä ÓÊÒÇÅÄ: 3002 10 99 00
Íàçâà âèðîáíèêà: Randox Laboratories Ltd., United Kingdom, United Kingdom
Àäðåñà âèðîáíèêà: Äàí³ â³äñóòí³
Íàçâà çàÿâíèêà: Äàí³ â³äñóòí³
²ÏÍ çàÿâíèêà: Äàí³ â³äñóòí³
Àäðåñà çàÿâíèêà: Äàí³ â³äñóòí³



Äîäàòêè äî ðåºñòðàö³éíîãî ñâ³äîöòâà âèðîáó Ðåàãåíòè äëÿ êë³í³÷íî¿ á³îõ³ì³¿:
¹ ï.ï.Ñåð³ÿÓêðà¿íñüêà íàçâàÍàçâà ó âèðîáíèêà
101. MA2864ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß Ì²ÊÐÎÀËÜÁÓ̲ÍÓ 4X50TMICROALBUMIN 4X50T
102. MA3828ÍÀÁ²Ð ÐÅÀÃÅÍҲ вÄÊÈÕ ÄËß ÂÈÇÍÀ×ÅÍÍß Ì²ÊÐÎÀËÜÁÓ̲ÍÓ R1 6X20, R2 3X8(6X95T)MICROALBUMIN (LIQUID), R1 6X20, R2 3X8(6X95T)
103. MC1379ÍÀÁ²Ð ÌÓËÜÒÈÊÎÍÒÐÎ˲ вÂÅÍÜ 1, 5X2MULTI CONTROL LEVEL 1, 5X2
104. MC1380ÍÀÁ²Ð ÌÓËÜÒÈÊÎÍÒÐÎ˲ вÂÅÍÜ 2, 5X2MULTI CONTROL LEVEL 2, 5X2
105. MC1381ÍÀÁ²Ð ÌÓËÜÒÈÊÎÍÒÐÎ˲ вÂÅÍÜ 3, 5X2MULTI CONTROL LEVEL 3, 5X2
106. MC1382ÍÀÁ²Ð ÌÓËÜÒÈÊÀ˲ÁÐÀÒÎвÂ, 3X2MULTICALIBRATOR, 3X2
107. ML2634ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ßÁËÓÍÅÂί ÊÈÑËÎÒÈ 4X10MALIC ACID 4X10
108. ML7305ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ßÁËÓÍÅÂί ÊÈÑËÎÒÈ R1 4X10, R2 1X10 (160T)MALIC ACID R1 4X10, R2 1X10 (160T)
109. MY2456ÍÀÁ²Ð ÊÀ˲ÁÐÀÒÎв ÄËß ÂÈÇÍÀ×ÅÍÍß Ì²ÎÃËÎÁ²ÍÓ,4X1MYOGLOBIN CALIB., 4X1
110. MY2127ÍÀÁ²Ð ÐÅÀÃÅÍҲ вÄÊÈÉ ÄËß ÂÈÇÍÀ×ÅÍÍß Ì²ÎÃËÎÁ²ÍÓ R1 1X7, R2 1X6MYOGLOBIN (LIQUID) R1 1X7, R2 1X6
111. RF2301ÍÀÁ²Ð ÊÀ˲ÁÐÀÒÎв ÐÅÂÌÀÒίÄÍÎÃÎ ÔÀÊÒÎÐÓ 5X1RHEUMATOID FACTOR CALIB. SERIES 5X1
112. RF1436ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ÐÅÂÌÀÒίÄÍÎÃÎ ÔÀÊÒÎÐÓ 100TRHEUMATOID FACTOR 100T
113. RF2716ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ÐÅÂÌÀÒίÄÍÎÃÎ ÔÀÊÒÎÐÓ 100TRHEUMATOID FACTOR 100T
114. RF2881ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ÐÅÂÌÀÒίÄÍÎÃÎ ÔÀÊÒÎÐÓ 4X40TRHEUMATOID FACTOR 4X40T
115. RF7980ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ÐÅÂÌÀÒίÄÍÎÃÎ ÔÀÊÒÎÐÓ R1 2X15, R2 1X10RHEUMATOID FACTOR R1 2X15, R2 1X10
116. RF7981ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ÐÅÂÌÀÒίÄÍÎÃÎ ÔÀÊÒÎÐÓ R1 6X50, R2 2X50RHEUMATOID FACTOR R1 6X50, R2 2X50
117. RF3836ÍÀÁ²Ð ÐÅÀÃÅÍҲ вÄÊÈÕ ÄËß ÂÈÇÍÀ×ÅÍÍß ÐÅÂÌÀÒίÄÍÎÃÎ ÔÀÊÒÎÐÓ, R1 2X20, R2 2X8 (2X110T)RHEUMATOID FACTOR (LIQUID), R1 2X20, R2 2X8 (2X110T)
118. RQ9125/AÍÀÁ²Ð ÊÎÍÒÐÎ˲ RIQAS ÄËß ÄÎÑË²ÄÆÅÍÜ ²ÌÌÓÍÎËÎò×ÍÈÕ RQ9125/ÀRIQAS IMMUNOASSAY RQ9125/A
119. RQ9125/BÍÀÁ²Ð ÊÎÍÒÐÎ˲ RIQAS ÄËß ÄÎÑË²ÄÆÅÍÜ ²ÌÌÓÍÎËÎò×ÍÈÕ RQ9125/BRIQAS IMMUNOASSAY RQ9125/B
120. RQ9125/CÍÀÁ²Ð ÊÎÍÒÐÎ˲ RIQAS ÄËß ÄÎÑË²ÄÆÅÍÜ ²ÌÌÓÍÎËÎò×ÍÈÕ RQ9125/ÑRIQAS IMMUNOASSAY RQ9125/C
121. RQ9130ÍÀÁ²Ð ÊÎÍÒÐÎ˲ RIQAS ÄËß ÄÎÑË²ÄÆÅÍÜ ²ÌÓÍÎËÎò×ÍÈÕ RQ9130RIQAS IMMUNOASSAY (MONTHLY) RQ9130
122. TF2865ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ÒÐÀÍÑÔÅÐÐÈÍÓ 4X40TTRANSFERRIN 4X40T
123. TF7197ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ÒÐÀÍÑÔÅÐÐÈÍÓ R1 6X20, R2 2X15TRANSFERRIN(LIQUID)
124. PA3843ÍÀÁ²Ð ÐÅÀÃÅÍҲ ÄËß ÂÈÇÍÀ×ÅÍÍß ÒÐÀÍÑÔÅÐÐÈÍÓ (ÏÐÅÀËÜÁÓÌÈÍÓ) R1 6X20, R2 3X11 (6X95T)TRANSTHYRETIN (PREALBUMIN)(LIQUID), R1 6X20, R2 3X11 (6X95T)
125. TF3831ÍÀÁ²Ð ÐÅÀÃÅÍҲ вÄÊÈÕ ÄËß ÂÈÇÍÀ×ÅÍÍß ÒÐÀÍÑÔÅÐÐÈÍÓ, R1 6X20,R2 3X14 (6X95T)TRANSFERRIN(LIQUID), R1 6X20,R2 3X14 (6X95T)
126. LIA 3105ÍÀÁ²Ð вÄÊÈÕ ²ÌÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÊÎÍÒÐÎ˲ вÂÅÍÜ 1, 12Õ5IMMUNAASSAY PREMIUM CONTROL LEVEL 1, 12Õ5
127. LIA 3106ÍÀÁ²Ð вÄÊÈÕ ²ÌÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÊÎÍÒÐÎ˲ вÂÅÍÜ 2, 12Õ5IMMUNAASSAY PREMIUM CONTROL LEVEL 2, 12Õ5
128. LIA 3107ÍÀÁ²Ð вÄÊÈÕ ²ÌÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÊÎÍÒÐÎ˲ вÂÅÍÜ 3, 12Õ5IMMUNAASSAY PREMIUM CONTROL LEVEL 3, 12Õ5
129. LIA 3108ÍÀÁ²Ð вÄÊÈÕ ²ÌÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÊÎÍÒÐÎ˲ ÒÐÈ-вÂÍÅÂÈÉ, 12Õ5IMMUNAASSAY PREMIUM CONTROL TRI-LEVEL, 12Õ5
130. IA 2638ÍÀÁ²Ð ²ÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÊÎÍÒÐÎ˲ вÂÅÍÜ 1, 12Õ5IMMUNAASSAY PREMIUM CONTROL LEVEL 1, 12Õ5
131. IA 2639ÍÀÁ²Ð ²ÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÊÎÍÒÐÎ˲ вÂÅÍÜ 2, 12Õ5IMMUNAASSAY PREMIUM CONTROL LEVEL 2, 12Õ5
132. IA 2640ÍÀÁ²Ð ²ÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÊÎÍÒÐÎ˲ вÂÅÍÜ 3, 12Õ5IMMUNAASSAY PREMIUM CONTROL LEVEL 3, 12Õ5
133. IA 2633ÍÀÁ²Ð ²ÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÊÎÍÒÐÎ˲ ÒÐÈвÂÍÅÂÈÉ, 12Õ5IMMUNAASSAY PREMIUM CONTROL TRI-LEVEL, 12Õ5
134. IA 3109ÍÀÁ²Ð ²ÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÏËÞÑ ÊÎÍÒÐÎ˲ вÂÅÍÜ 1, 12Õ5IMMUNAASSAY PREMIUM PLUS CONTROL LEVEL 1 , 12Õ5
135. IA 3110ÍÀÁ²Ð ²ÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÏËÞÑ ÊÎÍÒÐÎ˲ вÂÅÍÜ 2, 12Õ5IMMUNAASSAY PREMIUM PLUS CONTROL LEVEL 2, 12Õ5
136. IA 3111ÍÀÁ²Ð ²ÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÏËÞÑ ÊÎÍÒÐÎ˲ вÂÅÍÜ 3, 12Õ5IMMUNAASSAY PREMIUM PLUS CONTROL LEVEL 3, 12Õ5
137. IA 3112ÍÀÁ²Ð ²ÌÓÍÎËÎò×ÍÈÕ ÏÐÅ̲ÓÌ ÏËÞÑ ÊÎÍÒÐÎ˲ ÒÐÈ-вÂÍÅÂÈÉ, 12Õ5IMMUNAASSAY PREMIUM PLUS CONTROL TRI-LEVEL, 12Õ5
138. IAS 3113ÍÀÁ²Ð ÊÎÍÒÐÎ˲ ²ÌÓÍÎËÎò×ÍÈÕ ÑÏÅÖ²ÀËÜÍÈÕ ² вÂÅÍÜ 1, 5Õ2IMMUNAASSAY SPECIALITY I CONTROL LEVEL 1, 5Õ2
139. IAS 3114ÍÀÁ²Ð ÊÎÍÒÐÎ˲ ²ÌÓÍÎËÎò×ÍÈÕ ÑÏÅÖ²ÀËÜÍÈÕ ² вÂÅÍÜ 2, 5Õ2IMMUNAASSAY SPECIALITY I CONTROL LEVEL 2, 5Õ2
140. IAS 3115ÍÀÁ²Ð ÊÎÍÒÐÎ˲ ²ÌÓÍÎËÎò×ÍÈÕ ÑÏÅÖ²ÀËÜÍÈÕ ² вÂÅÍÜ 3, 5Õ2IMMUNAASSAY SPECIALITY I CONTROL LEVEL 3, 5Õ2
141. IAS 3117ÍÀÁ²Ð ÊÎÍÒÐÎ˲ ²ÌÓÍÎËÎò×ÍÈÕ ÑÏÅÖ²ÀËÜÍÈÕ ²² вÂÅÍÜ 1, 5Õ1IMMUNAASSAY SPECIALITY II CONTROL LEVEL 1, 5Õ1
142. IAS 3118ÍÀÁ²Ð ÊÎÍÒÐÎ˲ ²ÌÓÍÎËÎò×ÍÈÕ ÑÏÅÖ²ÀËÜÍÈÕ ²² вÂÅÍÜ 2, 5Õ1IMMUNAASSAY SPECIALITY II CONTROL LEVEL 2, 5Õ1
143. IAS 3119ÍÀÁ²Ð ÊÎÍÒÐÎ˲ ²ÌÓÍÎËÎò×ÍÈÕ ÑÏÅÖ²ÀËÜÍÈÕ ²² вÂÅÍÜ 3, 5Õ1IMMUNAASSAY SPECIALITY II CONTROL LEVEL 3, 5Õ1



Ñòîð³íêè: 1, [2]

Íà ñàéò³ òàêîæ øóêàþòü: Ìåáåíäàçîë ïðîòèïîêàçàííÿ, Íàòð³þ õëîðèä, Ñåïòåôðèë ³íñòðóêö³ÿ